VX-787 is an influenza inhibitor used in research to investigate its ability to inhibit the replication of influenza viruses, providing a potential therapeutic pathway for flu treatment.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
